Kang, Joon Hee <br/><br/>
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.  [electronic resource] 

 -  Oncotarget  Aug 2016 
 - 49397-49410 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.10354  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials<br/>Adenosine Triphosphate--metabolism<br/>Aldehyde Dehydrogenase--antagonists & inhibitors<br/>Animals<br/>Aspartic Acid--metabolism<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Cytosol--metabolism<br/>Female<br/>Gossypol--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Malates--metabolism<br/>Membrane Potential, Mitochondrial<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mitochondria--metabolism<br/>NAD--metabolism<br/>NADP--metabolism<br/>Neoplasm Transplantation<br/>Oxidative Phosphorylation<br/>Oxidoreductases Acting on CH-NH Group Donors<br/>Phenformin--administration & dosage<br/>RNA, Small Interfering--metabolism